Greece

 

HBI 2022: How digitalisation is driving a service revolution

The arguments for digitalisation in healthcare services are well-established, and thanks to the pandemic, hybrid models are coming more and more to the fore. How is digitalisation being used to improve financial outcomes, and how is data being used to deliver unprecedented proactive and preventative measures? 

Affidea deal – underbidders and EBITDA

HBI hears that the surprise buyer of European imaging and cancer treatment provider Affidea, Groupe Bruxelles Lambert (GBL) may not have been the highest bidder, despite winning out. HBI considers who else was in the running, and the EBITDA figure that may have been used for the deal.

Affidea bought by Groupe Bruxelles Lambert

Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.

Affidea sale – potential price and buyers

European imaging and cancer treatment provider Affidea is for sale according to multiple sources. HBI chats to an operator source to find about more about the sale and to speculate on price and purchasers.

Europe’s carer-booking market to pick up with new entrants

Doctor-booking platforms is an established multi-million euro market in Europe. However, platforms that connect families with carers have so far lagged behind. That is starting to change with the emergence of new carer-booking platforms that want to internationalise. HBI speaks to one, Greece's grandmama.

Find Us